Most Cited Articles

Open access

ISSN: 2589-238X

A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage

Share article

Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage

Share article

Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series

Share article

Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm

Share article

Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes

Share article

Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?

Share article

Increased plasma periostin concentration predicts angiographic vasospasm development in non-severe aneurysmal subarachnoid hemorrhage

Share article

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.

Production and hosting by Elsevier on behalf of KeAi Communications Co. Ltd